会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 45. 发明专利
    • Novel 1-oxa-1-dethia-cephalosporin derivative
    • 新型1-OXA-1-DETHIA-CEPHALOSPORIN衍生物
    • JPS5946287A
    • 1984-03-15
    • JP12757482
    • 1982-07-23
    • Meiji Seika Kaisha LtdMerck & Co Inc
    • SHIBAHARA MASAYUKIOKONOGI TSUNEOMURAI YASUSHIFUKATSU SHIYUNZOUNIIDA TAROUWAKAZAWA TADASHI
    • A61K31/535A61P31/04C07D205/085C07D403/12C07D505/00C07F9/568
    • C07D403/12C07D205/085C07D505/00C07F9/5683Y02P20/55
    • NEW MATERIAL:The compound of formula I {R is group of formula II (R1 is 2- or 3-thienyl; R2 is H or carboxy) or formula III [R3 is H or (carboxy)-lower alkyl]; R4 is H or methoxy; R5 is lower alkyl; R6 is group of formula IV [Het is (substituted) heterocyclic group]}. EXAMPLE:7-( 2-Thienylacetamido )-2alpha-methyl-4-( 1-methyl-1H-tetrazol-5-yl )-thiomethyl-1-oxa-1-dethia-3-cephem-4-carboxylic acid. USE:Antibacterial agent. Antibiotic substance useful for the remedy and prevention of bacterial infectious diseases. PROCESS:The objective compound can be prepared by condensing the compound of formula V (A is carboxyl-protecting group) with a carboxylic acid (or its reactive derivative) in an organic solvent (e.g. methylene chloride), and eliminating the protecting group e.g. with an acid. The compound of formula V is a novel substance, which can be synthesized e.g. from the compound of formula VIvia several steps.
    • 新物质:式Ⅰ化合物(R为式Ⅱ的基团(R1为2-或3-噻吩基; R2为H或羧基)或式Ⅲ[R3为H或(羧基) - 低级烷基]; R4是H或甲氧基; R5是低级烷基; R6是式IV的基团[Het是(取代的)杂环基]]。 实施例7-(2-噻吩乙酰氨基)-2α-甲基-4-(1-甲基-1H-四唑-5-基)硫甲基-1-氧杂-1-脱硫-3-头孢烯-4-羧酸。 用途:抗菌剂。 用于治疗和预防细菌感染性疾病的抗生素物质。 方法:目标化合物可以通过在有机溶剂(例如二氯甲烷)中将式V化合物(A为羧基保护基)与羧酸(或其反应性衍生物)缩合而制备,并除去保护基团。 与酸。 式V化合物是一种新型物质,其可以合成例如 由式VI化合物通过几个步骤。
    • 46. 发明专利
    • 1-oxadethiacephalosporin compound and antibacterial agent containing the same
    • 1-OXADETHIACEPHALOSPORIN化合物和含有它的抗菌剂
    • JPS5910591A
    • 1984-01-20
    • JP11863782
    • 1982-07-09
    • Meiji Seika Kaisha Ltd
    • SHIBAHARA MASAYUKIOKONOGI TSUNEOMURAI YASUSHIFUKATSU SHIYUNZOUNIIDA TAROUWAKAZAWA TADASHI
    • C07D498/04A61K31/535A61K31/545A61K31/546A61P31/04C07D501/36C07D505/00
    • C07D505/00Y02P20/55
    • NEW MATERIAL:The compound of formula I {R
      1 is 1W4C alkyl; R
      2 is group of formula II (R
      3 is H or carboxyl), or formula III [R
      4 is H or amino; R
      5 is 1W 4C alkyl or group of formula IV (R
      6 and R
      7 are H or 1W4C alkyl)]}, its salt and its ester.
      EXAMPLE: 7-( 2- Thienylacetamido)1-oxa- 1-dethia-3- methylthio- 3-cephem- 4-carboxylic acid of formula V.
      USE: Antibacterial agent which can be administered orally as well as parenterally. It has excellent antibacterial activites not only to Gram-positive bacteria but also to Gram-negative bacteria.
      PROCESS: The objective compound is prepared, e.g. by reacting (acylating) the 7- amino group of the 1-oxadethia-3-alkylthio-7-aminocephem compound of formula VI(R
      8 is H or carboxyl-protecting group) with the thienyl compound of formula VII[ R
      9 is H or (protected) carboxyl; -COR
      10 is carboxyl or its reactive derivative group], and if necessary, eliminating the protecting group.
      COPYRIGHT: (C)1984,JPO&Japio
    • 新材料:式I化合物{R1为1-4C烷基; R2是式II的基团(R3是H或羧基)或式III [R4是H或氨基; R5为1-4C烷基或式IV基团(R6和R7为H或1-4C烷基)]},其盐及其酯。 实施例:具有式V的7-(2-噻吩乙酰氨基)1-氧杂-1-脱硫-3-甲硫基-3-头孢烯-4-羧酸。用途:可以口服和肠胃外给药的抗菌剂。 它具有优异的抗菌活性,不仅对革兰氏阳性菌,而且对革兰氏阴性细菌。 方法:目标化合物如 通过使式VI(R 8为H或羧基保护基)的1-恶嗪-3-烷硫基-7-氨基头孢烯化合物的7-氨基与式VII的噻吩基化合物反应(酰化)[R 9为H或( 保护)羧基; -COR10是羧基或其反应性衍生物基团],如果需要,除去保护基。